COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

被引:130
|
作者
Chi, Wei-Yu [1 ]
Li, Yen-Der [2 ]
Huang, Hsin-Che [3 ]
Chan, Timothy En Haw [4 ,5 ,6 ]
Chow, Sih-Yao [7 ]
Su, Jun-Han [2 ]
Ferrall, Louise [8 ]
Hung, Chien-Fu [8 ,9 ,10 ]
Wu, T-C [8 ,9 ,10 ,11 ,12 ]
机构
[1] Weill Cornell Med, Physiol Biophys & Syst Biol Grad Program, New York, NY USA
[2] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[3] Mem Sloan Kettering Canc Ctr, Triinst PhD Program Chem Biol, 1275 York Ave, New York, NY 10021 USA
[4] Max Planck Inst Immunobiol & Epigenet, Int Max Planck Res Sch Immunobiol Epigenet & Meta, Freiburg, Germany
[5] Univ Freiburg, Med Ctr, Dept Urol, Freiburg, Germany
[6] Univ Freiburg, Fac Biol, Freiburg, Germany
[7] EirGenix Inc, Downstream Proc Sci, Hsinchu, Taiwan
[8] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA
[9] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA
[10] Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD 21218 USA
[11] Johns Hopkins Univ, Dept Microbiol & Immunol, Baltimore, MD 21218 USA
[12] Johns Hopkins Med Inst, CRB 2 Room 309,1550 Orleans St, Baltimore, MD 21231 USA
关键词
COVID-19; Vaccine; Immunity; Variant; SARS-CoV-2; NCOV-19; AZD1222; VACCINE; MESSENGER-RNA; CHADOX1; BNT162B2; SINGLE-BLIND; NEUTRALIZING ANTIBODY; OMICRON VARIANT; NON-INFERIORITY; UNITED-STATES; IMMUNOGENICITY;
D O I
10.1186/s12929-022-00853-8
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Coronavirus Disease 2019 (COVID-19) has been the most severe public health challenge in this century. Two years after its emergence, the rapid development and deployment of effective COVID-19 vaccines have successfully controlled this pandemic and greatly reduced the risk of severe illness and death associated with COVID-19. However, due to its ability to rapidly evolve, the SARS-CoV-2 virus may never be eradicated, and there are many important new topics to work on if we need to live with this virus for a long time. To this end, we hope to provide essential knowledge for researchers who work on the improvement of future COVID-19 vaccines. In this review, we provided an up-to-date summary for current COVID-19 vaccines, discussed the biological basis and clinical impact of SARS-CoV-2 variants and subvariants, and analyzed the effectiveness of various vaccine booster regimens against different SARS-CoV-2 strains. Additionally, we reviewed potential mechanisms of vaccine-induced severe adverse events, summarized current studies regarding immune correlates of protection, and finally, discussed the development of next-generation vaccines.
引用
收藏
页数:27
相关论文
共 50 条
  • [21] Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
    Sui, Yongjun
    Bekele, Yonas
    Berzofsky, Jay A.
    PATHOGENS, 2021, 10 (02): : 1 - 11
  • [22] COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era
    Ender Volkan
    Molecular Biotechnology, 2021, 63 : 885 - 897
  • [23] Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines
    Park, Heedo
    Park, Mee Sook
    Seok, Jong Hyeon
    You, Jaehwan
    Kim, Jineui
    Kim, Jeonghun
    Park, Man-Seong
    JOURNAL OF MICROBIOLOGY, 2022, 60 (03) : 308 - 320
  • [24] Rapid Evaluation of Vaccine Booster Effectiveness against SARS-CoV-2 Variants
    Cheng, Hoi Lok
    Lim, Sing Mei
    Jia, Huan
    Chen, Ming Wei
    Ng, Say Yong
    Gao, Xiaohong
    Somani, Jyoti
    Sengupta, Sharmila
    Tay, Dousabel M. Y.
    Chua, Patrina W. L.
    Abirami, R.
    Ling, Sharon Y. H.
    McBee, Megan E.
    Young, Barnaby E.
    Sikes, Hadley D.
    Preiser, Peter R.
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [25] Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
    Kumari, Monika
    Su, Shih-Chieh
    Liang, Kang-Hao
    Lin, Hsiu-Ting
    Lu, Yu-Feng
    Chen, Kai-Chi
    Chen, Wan-Yu
    Wu, Han-Chung
    JOURNAL OF BIOMEDICAL SCIENCE, 2023, 30 (01)
  • [26] Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies
    Bian, Lianlian
    Gao, Fan
    Zhang, Jialu
    He, Qian
    Mao, Qunying
    Xu, Miao
    Liang, Zhenglun
    EXPERT REVIEW OF VACCINES, 2021, 20 (04) : 365 - 373
  • [27] Would New SARS-CoV-2 Variants Change the War against COVID-19?
    Redwan, Elrashdy M.
    Elrashdy, Fatma
    Aljabali, Alaa A. A.
    Baetas-da-Cruz, Wagner
    Barh, Debmalya
    Brufsky, Adam M.
    Hassan, Sk. Sarif
    Lundstrom, Kenneth
    Serrano-Aroca, Angel
    Takayama, Kazuo
    Tambuwala, Murtaza M.
    Uhal, Bruce D.
    Uversky, Vladimir N.
    EPIDEMIOLOGIA, 2022, 3 (02): : 229 - 237
  • [28] SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies
    Gong, Wenping
    Parkkila, Seppo
    Wu, Xueqiong
    Aspatwar, Ashok
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2023, 42 (06) : 393 - 414
  • [29] Effectiveness of COVID-19 Vaccines and Antiviral Therapies in the Era of SARS-CoV-2 Variants
    Unuvar, Gamze Kalin
    Rello, Jordi
    Alp, Emine
    ERCIYES MEDICAL JOURNAL, 2023, 45 (01) : 1 - 7
  • [30] Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
    Anand, Uttpal
    Jakhmola, Shweta
    Indari, Omkar
    Jha, Hem Chandra
    Chen, Zhe-Sheng
    Tripathi, Vijay
    Perez de la Lastra, Jose M.
    FRONTIERS IN IMMUNOLOGY, 2021, 12